Sodium MRI of multiple sclerosis.

Maria Petracca, Lazar Fleysher, Niels Oesingmann, Matilde Inglese

Journal: NMR in biomedicine 2016;29(2):153-61

PMID: 25851455

Abstract

Multiple sclerosis (MS) is the most common cause of non-traumatic disability in young adults. The mechanisms underlying neurodegeneration and disease progression are poorly understood, in part as a result of the lack of non-invasive methods to measure and monitor neurodegeneration in vivo. Sodium MRI is a topic of increasing interest in MS research as it allows the metabolic characterization of brain tissue in vivo, and integration with the structural information provided by (1)H MRI, helping in the exploration of pathogenetic mechanisms and possibly offering insights into disease progression and monitoring of treatment outcomes. We present an up-to-date review of the sodium MRI application in MS organized into four main sections: (i) biological and pathogenetic role of sodium; (ii) brief overview of sodium imaging techniques; (iii) results of sodium MRI application in clinical studies; and (iv) future perspectives.

Copyright © 2015 John Wiley & Sons, Ltd.

Address: Department of Neurology, Icahn School of Medicine, Mount Sinai, New York, USA.; Department of Neuroscience, Federico II University, Naples, Italy.; Department of Radiology, Icahn School of Medicine, Mount Sinai, New York, USA.; Siemens Healthcare, New York, USA.; Department of Neuroscience, Icahn School of Medicine, Mount Sinai, New York, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.